Literature DB >> 29307592

Complex noradrenergic dysfunction in Alzheimer's disease: Low norepinephrine input is not always to blame.

Mary Gannon1, Qin Wang2.   

Abstract

The locus coeruleus-noradrenergic (LC-NA) system supplies the cerebral cortex with norepinephrine, a key modulator of cognition. Neurodegeneration of the LC is an early hallmark of Alzheimer's disease (AD). In this article, we analyze current literature to understand whether NA degeneration in AD simply leads to a loss of norepinephrine input to the cortex. With reported adaptive changes in the LC-NA system at the anatomical, cellular, and molecular levels in AD, existing evidence support a seemingly sustained level of extracellular NE in the cortex, at least at early stages of the long course of AD. We postulate that loss of the integrity of the NA system, rather than mere loss of NE input, is a key contributor to AD pathogenesis. A thorough understanding of NA dysfunction in AD has a large impact on both our comprehension and treatment of this devastating disease.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Dysfunction; Locus coeruleus; Noradrenergic; Norepinephrine

Year:  2018        PMID: 29307592      PMCID: PMC6855395          DOI: 10.1016/j.brainres.2018.01.001

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  110 in total

Review 1.  Alzheimer's pathogenesis: is there neuron-to-neuron propagation?

Authors:  Heiko Braak; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2011-04-24       Impact factor: 17.088

2.  Propranolol restores cognitive deficits and improves amyloid and Tau pathologies in a senescence-accelerated mouse model.

Authors:  Marta Dobarro; Lourdes Orejana; Norberto Aguirre; María Javier Ramírez
Journal:  Neuropharmacology       Date:  2012-07-21       Impact factor: 5.250

3.  Effects of Alzheimer's disease severity on cerebrospinal fluid norepinephrine concentration.

Authors:  R Elrod; E R Peskind; L DiGiacomo; K I Brodkin; R C Veith; M A Raskind
Journal:  Am J Psychiatry       Date:  1997-01       Impact factor: 18.112

4.  Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease.

Authors:  Pamela J McMillan; Sylvia S White; Allyn Franklin; J Lynne Greenup; James B Leverenz; Murray A Raskind; Patricia Szot
Journal:  Brain Res       Date:  2010-12-11       Impact factor: 3.252

5.  Changes in the brain catecholamines in patients with dementia of Alzheimer type.

Authors:  R Adolfsson; C G Gottfries; B E Roos; B Winblad
Journal:  Br J Psychiatry       Date:  1979-09       Impact factor: 9.319

6.  Blocking beta2-adrenergic receptor attenuates acute stress-induced amyloid beta peptides production.

Authors:  Nan-Nan Yu; Xiang-Xiang Wang; Jin-Tai Yu; Nai-Dong Wang; Rui-Chun Lu; Dan Miao; Yan Tian; Lan Tan
Journal:  Brain Res       Date:  2010-01-06       Impact factor: 3.252

7.  Characteristics of behavioral abnormalities in alpha1d-adrenoceptors deficient mice.

Authors:  Kenichi Mishima; Akito Tanoue; Masakazu Tsuda; Nobuyoshi Hasebe; Yoshihiko Fukue; Nobuaki Egashira; Yukio Takano; Hiro-O Kamiya; Gozoh Tsujimoto; Katsunori Iwasaki; Michihiro Fujiwara
Journal:  Behav Brain Res       Date:  2004-07-09       Impact factor: 3.332

8.  Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.

Authors:  Marta Dobarro; Gorka Gerenu; María J Ramírez
Journal:  Int J Neuropsychopharmacol       Date:  2013-06-17       Impact factor: 5.176

Review 9.  Noradrenergic modulation of cognition: therapeutic implications.

Authors:  Samuel R Chamberlain; Trevor W Robbins
Journal:  J Psychopharmacol       Date:  2013-03-21       Impact factor: 4.153

10.  Noradrenergic control of odor recognition in a nonassociative olfactory learning task in the mouse.

Authors:  Alexandra Veyrac; Véronique Nguyen; Marc Marien; Anne Didier; François Jourdan
Journal:  Learn Mem       Date:  2007-12-17       Impact factor: 2.460

View more
  18 in total

Review 1.  Pharmacological Management of Apathy in Dementia.

Authors:  Laiba Azhar; Raphael W Kusumo; Giovanni Marotta; Krista L Lanctôt; Nathan Herrmann
Journal:  CNS Drugs       Date:  2022-01-10       Impact factor: 5.749

Review 2.  Emotion Processing Dysfunction in Alzheimer's Disease: An Overview of Behavioral Findings, Systems Neural Correlates, and Underlying Neural Biology.

Authors:  Shefali Chaudhary; Simon Zhornitsky; Herta H Chao; Christopher H van Dyck; Chiang-Shan R Li
Journal:  Am J Alzheimers Dis Other Demen       Date:  2022 Jan-Dec       Impact factor: 2.632

Review 3.  Noradrenergic Modulation of the Piriform Cortex: A Possible Avenue for Understanding Pre-Clinical Alzheimer's Disease Pathogenesis.

Authors:  Vishaal Rajani; Qi Yuan
Journal:  Front Cell Neurosci       Date:  2022-05-26       Impact factor: 6.147

Review 4.  Combination Drug Therapy for the Management of Alzheimer's Disease.

Authors:  Md Tanvir Kabir; Md Sahab Uddin; Abdullah Al Mamun; Philippe Jeandet; Lotfi Aleya; Rasha A Mansouri; Ghulam Md Ashraf; Bijo Mathew; May N Bin-Jumah; Mohamed M Abdel-Daim
Journal:  Int J Mol Sci       Date:  2020-05-05       Impact factor: 5.923

5.  Arousal increases neural gain via the locus coeruleus-norepinephrine system in younger adults but not in older adults.

Authors:  Tae-Ho Lee; Steven G Greening; Taiji Ueno; David Clewett; Allison Ponzio; Michiko Sakaki; Mara Mather
Journal:  Nat Hum Behav       Date:  2018-05-07

6.  Impaired Phasic Discharge of Locus Coeruleus Neurons Based on Persistent High Tonic Discharge-A New Hypothesis With Potential Implications for Neurodegenerative Diseases.

Authors:  Kathrin Janitzky
Journal:  Front Neurol       Date:  2020-05-12       Impact factor: 4.003

Review 7.  Locus coeruleus in memory formation and Alzheimer's disease.

Authors:  Tony James; Bartosz Kula; Seowon Choi; Shahzad S Khan; Lane K Bekar; Nathan A Smith
Journal:  Eur J Neurosci       Date:  2020-11-15       Impact factor: 3.386

Review 8.  Noradrenaline in the aging brain: Promoting cognitive reserve or accelerating Alzheimer's disease?

Authors:  Mara Mather
Journal:  Semin Cell Dev Biol       Date:  2021-06-04       Impact factor: 7.499

Review 9.  Noradrenergic Hypothesis Linking Neurodegeneration-Based Cognitive Decline and Astroglia.

Authors:  Giampiero Leanza; Rosario Gulino; Robert Zorec
Journal:  Front Mol Neurosci       Date:  2018-07-27       Impact factor: 5.639

10.  β-amyloid redirects norepinephrine signaling to activate the pathogenic GSK3β/tau cascade.

Authors:  Fang Zhang; Mary Gannon; Yunjia Chen; Shun Yan; Sixue Zhang; Wendy Feng; Jiahui Tao; Bingdong Sha; Zhenghui Liu; Takashi Saito; Takaomi Saido; C Dirk Keene; Kai Jiao; Erik D Roberson; Huaxi Xu; Qin Wang
Journal:  Sci Transl Med       Date:  2020-01-15       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.